Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Heather J. Logghe, MD, Tyler Rouse, MD, Alec Beekley, MD, and Rajesh Aggarwal, MD, PhD
Modern surgeons are diverse, socially adept, and differ in other important ways from the stereotype of a technically gifted white male with poor bedside manner.
AMA J Ethics. 2018;20(5):492-500. doi:
10.1001/journalofethics.2018.20.5.mhst1-1805.
Two pediatric cases highlight risks of prolonging anesthetic exposure for training purposes and prompt questions about influences of surgical training on outcomes.
AMA J Ethics. 2020;22(4):E267-275. doi:
10.1001/amajethics.2020.267.
Lee C. Zhao, MD, Gaines Blasdel, Augustus Parker, and Rachel Bluebond-Langner, MD
Tension between realistic goals and unrealistic views about how to achieve them is compounded when patients are eager to revise a prior surgeon’s gender-affirming procedure.
AMA J Ethics. 2023;25(6):E391-397. doi:
10.1001/amajethics.2023.391.
Feminism plays critical roles in innovating health care policies and practices. Feminist insights into clinicians as gatekeepers to gender-transition interventions can help resist tendencies to pathologize transgender.
AMA J Ethics. 2016;18(11):1132-1138. doi:
10.1001/journalofethics.2016.18.11.msoc1-1611.
One transgender patient draws upon his transition experiences to suggest strategies for health care professionals looking to be more responsive to transgender patients’ needs.
AMA J Ethics. 2016;18(11):1139-1146. doi:
10.1001/journalofethics.2016.18.11.mnar1-1611.